| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 15 | |
| #2 | United States | 11 | |
| #3 | China | 8 | |
| #4 | Canada | 6 | |
| #5 | EPO (European Patent Office) | 6 | |
| #6 | Israel | 5 | |
| #7 | Mexico | 4 | |
| #8 | Japan | 3 | |
| #9 | Hungary | 2 | |
| #10 | Philippines | 2 | |
| #11 | EAPO (Eurasian Patent Organization) | 1 | |
| #12 | WIPO (World Intellectual Property Organization) | 1 | |
| #13 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Organic fine chemistry | |
| #5 | Basic materials chemistry | |
| #6 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Analysing materials | |
| #5 | Microorganisms | |
| #6 | Measuring microorganism processes | |
| #7 | Special acyclic compounds | |
| #8 | Preservation of human bodies | |
| #9 | Enzymes | |
| #10 | Combinatorial chemistry |
| # | Name | Total Patents |
|---|---|---|
| #1 | Nitsch Roger | 18 |
| #2 | Grimm Jan | 16 |
| #3 | Tissot Kathrin | 16 |
| #4 | Knobloch Marlen | 16 |
| #5 | Hock Christoph | 16 |
| #6 | Esslinger Christoph | 13 |
| #7 | Roger Nitsch | 6 |
| #8 | Jabbar Abdul | 4 |
| #9 | Hock Christoph Prof | 4 |
| #10 | Gasser Robin B | 4 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020226993A1 | Treatment of brain ischemia-reperfusion injury | |
| EP3673050A1 | Bioengineered in vitro 3d model of human atherosclerotic plaque | |
| AU2015218437A1 | Method of Promoting Neurogenesis | |
| AU2013204620A1 | Method of Providing Disease-Specific Binding Molecules and Targets | |
| AU2011265453A1 | Method of providing disease-specific binding molecules and targets | |
| MX360580B | Human anti-alpha-synuclein autoantibodies. | |
| ZA200904700B | Method of providing disease-specific binding molecules and targets | |
| AU2008261212A1 | Treatment for Alzheimer' s disease | |
| AU2002235924A8 | Cyp46 genotype determination for risk and treatment evaluation of alzheimer's disease | |
| AU1686701A | Dispatched polypeptides |